SECTION NUMBER SECTION TITLE QUESTIONS TOTAL
------------------------------------------------------------------------------------
Section 1 AADSM Standards and Protocols 1 - 10 10
Section 2 Sleep Physiology and Architecture 11 - 25 15
Section 3 Obstructive Sleep Apnea Pathophysiology 26 - 60 35
Section 4 Diagnostic Methods and Sleep Testing 61 - 110 50
Section 5 Oral Appliance Therapy (OAT) 111 - 200 90
Section 6 Clinical Case Scenarios 201 - 250 50
Section 7 Comorbidities and Systemic Effects 251 - 285 35
Section 8 Pediatric and Geriatric Sleep Medicine 286 - 315 30
Section 9 Advanced Diagnostics 316 - 340 25
Section 10 Treatment Alternatives 341 - 370 30
Section 11 Pharmacology in Sleep Medicine 371 - 390 20
Section 12 Sleep Study Scoring and Interpretation 391 - 420 30
Section 13 Legal and Ethical Considerations 421 - 435 15
Section 14 Patient Communication and Counseling 436 - 445 10
Section 15 Emerging Therapies and Research 446 - 455 10
Section 16 Board-Style Comprehensive Review 456 - 465 10
TOTAL 1 - 465 465
[1]
,SECTION 1: AADSM STANDARDS AND PROTOCOLS
1. Which of the following is NOT part of AADSM standard protocol for long term OAT follow
up?
A. Evaluation for dental side effects
B. Recording vitals
C. Assessment of subjective symptoms
D. Assessment with objective home sleep testing
Answer: B. Recording vitals
Rationale: The American Academy of Dental Sleep Medicine (AADSM) standard protocol
for long-term oral appliance therapy (OAT) follow-up focuses on dental and sleep-related
outcomes. Recording vitals is not a standard component of the AADSM protocol, though it
may be performed in medical settings. The key elements include evaluating dental side
effects (tooth movement, occlusal changes, TMJ issues), assessing subjective symptoms
(daytime sleepiness, snoring, sleep quality), and objective sleep testing to verify
therapeutic efficacy. Regular dental evaluations are essential to monitor for adverse effects
on the dentition and occlusion.
2. The AADSM recommendation for OAT long term patient follow-up evaluation is:
A. annually.
B. every six months for the first year then annually.
C. every six months.
D. after six months then annually.
Answer: B. every six months for the first year then annually.
Rationale: The AADSM recommends more frequent follow-up during the initial treatment
period to ensure proper appliance fit, assess treatment response, and monitor for adverse
effects. After the first year of successful therapy with stable outcomes, the interval can be
extended to annual visits. This approach allows for early detection of problems such as
occlusal changes, TMJ discomfort, or loss of therapeutic efficacy. The initial six-month
[2]
,follow-up is critical for verifying that the appliance continues to maintain proper
mandibular advancement and airway patency.
3. According to AADSM guidelines, which of the following is a minimum requirement for
initiating oral appliance therapy?
A. A formal sleep study confirming OSA diagnosis
B. A trial of CPAP therapy
C. A dental examination only
D. Patient self-report of snoring
Answer: A. A formal sleep study confirming OSA diagnosis
Rationale: The AADSM guidelines mandate that oral appliance therapy should only be
initiated after a definitive diagnosis of obstructive sleep apnea has been established
through objective sleep testing (polysomnography or home sleep apnea testing). This
ensures that patients with other causes of sleep-disordered breathing or non-OSA
conditions are not inappropriately treated. The diagnostic sleep study provides baseline
AHI/RDI values that are essential for determining treatment efficacy and monitoring
response to therapy. Dental examination alone or patient self-report is insufficient for
treatment initiation.
4. What is the recommended frequency for objective sleep testing following initiation of
OAT?
A. Within 3 months of appliance delivery
B. Within 6 months of appliance delivery
C. Within 12 months of appliance delivery
D. Only if symptoms persist
Answer: B. Within 6 months of appliance delivery
Rationale: The AADSM recommends objective sleep testing within 6 months of initiating
OAT to verify therapeutic efficacy. This testing is essential to confirm that the appliance is
adequately controlling the patient's sleep-disordered breathing. Subjective improvement
alone is insufficient, as patients may feel better despite residual OSA, which carries ongoing
cardiovascular and neurocognitive risks. The follow-up sleep study allows for appliance
[3]
, adjustment if the AHI remains elevated or if the patient has not achieved adequate
response.
5. Which of the following dental findings requires immediate attention during OAT follow-
up?
A. Mild morning jaw stiffness
B. Minor tooth tenderness lasting less than 1 hour
C. Progressive occlusal changes on bite registration
D. Temporary salivation changes
Answer: C. Progressive occlusal changes on bite registration
Rationale: Progressive occlusal changes indicate that the appliance is causing significant
dental movement that could lead to irreversible bite changes. This requires prompt
intervention, which may include appliance adjustment, occlusal equilibration, or
consideration of alternative treatment. Mild morning jaw stiffness, brief tooth tenderness,
and temporary salivation changes are common initial side effects that typically resolve
with adaptation. However, progressive occlusal changes represent a more serious
complication that can have long-term consequences for the patient's dentition and
occlusion.
6. In the context of OAT, what does "tiratable" mean?
A. The appliance can be adjusted to incrementally advance the mandible
B. The appliance is made of durable materials
C. The appliance can be worn in either arch
D. The appliance has adjustable retention
Answer: A. The appliance can be adjusted to incrementally advance the mandible
Rationale: A titratable oral appliance is designed to allow gradual, incremental
advancement of the mandible to achieve optimal therapeutic effect. This feature is crucial
because the effective advancement required varies among patients, and starting with
maximum advancement could cause TMJ or dental discomfort. The titratable design
enables the clinician to start at a comfortable position and systematically advance the
mandible until symptoms improve or the patient reaches the maximum tolerated position,
balancing therapeutic efficacy with patient comfort.
[4]